Compare BLTE & CRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLTE | CRC |
|---|---|---|
| Founded | 2018 | 2014 |
| Country | United States | United States |
| Employees | N/A | 2500 |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 5.5B |
| IPO Year | 2021 | N/A |
| Metric | BLTE | CRC |
|---|---|---|
| Price | $137.17 | $62.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $198.00 | $72.57 |
| AVG Volume (30 Days) | 99.6K | ★ 745.5K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $12.37 |
| Revenue Next Year | $492.11 | N/A |
| P/E Ratio | ★ N/A | $13.50 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $56.68 | $41.88 |
| 52 Week High | $200.00 | $71.98 |
| Indicator | BLTE | CRC |
|---|---|---|
| Relative Strength Index (RSI) | 31.51 | 46.71 |
| Support Level | $103.94 | $61.52 |
| Resistance Level | $172.02 | $66.35 |
| Average True Range (ATR) | 7.11 | 2.38 |
| MACD | -1.16 | 0.02 |
| Stochastic Oscillator | 7.06 | 33.76 |
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.
California Resources Corp is an independent oil and natural gas exploration and production company. The company has operations spread across different properties in several oil and gas exploration basins in California and Utah, such as the Midway-Sunset, South Belridge, and McKittrick fields, in the San Joaquin Basin, and other properties located in Los Angeles, Sacramento, Uinta, and the Ventura and Salinas basins. Additionally, the company is focused on maximizing the value of its land, mineral ownership, and energy expertise for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects. Its business is organized into two reporting segments: oil and natural gas, which generate maximum revenue, and carbon management.